Siga Technologies INC Fair Value Adjustment of Warrants
Siga Technologies INC (SIGA) reported Fair Value Adjustment of Warrants of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-11.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2025-03-11
- Siga Technologies INC fair value adjustment of warrants for the quarter ending 2023-12-31 was $0.00.
- Siga Technologies INC fair value adjustment of warrants for the quarter ending 2023-09-30 was $0.00.
- Siga Technologies INC fair value adjustment of warrants for the quarter ending 2023-06-30 was $0.00, a 100.00% decline year-over-year.
- Siga Technologies INC fair value adjustment of warrants for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- Siga Technologies INC fair value adjustment of warrants for fiscal 2024 was $0.00.
- Siga Technologies INC fair value adjustment of warrants for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Siga Technologies INC fair value adjustment of warrants for fiscal 2022 was $400.66K, a 240.21% increase from fiscal 2021.
- Siga Technologies INC fair value adjustment of warrants for fiscal 2021 was $117.77K.
| Period end | Fair Value Adjustment of Warrants | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-11 | ||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $0.00 derived: sum of 2 quarters · filed 2025-03-11 | $0.00 derived: sum of 3 quarters · filed 2025-03-11 | $0.00 10-K · filed 2025-03-11 | |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-07 | $0.00 derived: sum of 2 quarters · filed 2023-11-07 | $0.00 10-Q · filed 2023-11-07 | $0.00 derived: sum of 4 quarters · filed 2025-03-11 | |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-08 | $0.00 10-Q · filed 2023-08-08 | $0.00 derived: sum of 3 quarters · filed 2025-03-11 | $0.00 derived: sum of 4 quarters · filed 2025-03-11 | |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-04 | $0.00 derived: sum of 2 quarters · filed 2025-03-11 | $0.00 derived: sum of 3 quarters · filed 2025-03-11 | $49.56K derived: sum of 4 quarters · filed 2025-03-11 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $0.00 derived: sum of 2 quarters · filed 2025-03-11 | $49.56K derived: sum of 3 quarters · filed 2025-03-11 | $400.66K 10-K · filed 2025-03-11 | |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-07 | $49.56K derived: sum of 2 quarters · filed 2023-11-07 | $400.66K 10-Q · filed 2023-11-07 | $223.88K derived: sum of 4 quarters · filed 2024-03-12 | |
| 2022-06-30 | $49.56K 10-Q · filed 2023-08-08 | $400.66K 10-Q · filed 2023-08-08 | $223.88K derived: sum of 3 quarters · filed 2024-03-12 | $223.88K derived: sum of 4 quarters · filed 2024-03-12 | |
| 2022-03-31 | $351.10K 10-Q · filed 2023-05-04 | $174.33K derived: sum of 2 quarters · filed 2024-03-12 | $174.33K derived: sum of 3 quarters · filed 2024-03-12 | $602.45K derived: sum of 4 quarters · filed 2024-03-12 | |
| 2021-12-31 | -$176.78K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | -$176.78K derived: sum of 2 quarters · filed 2024-03-12 | $251.35K derived: sum of 3 quarters · filed 2024-03-12 | $117.77K 10-K · filed 2024-03-12 | |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-03 | $428.13K derived: sum of 2 quarters · filed 2022-11-03 | $294.55K 10-Q · filed 2022-11-03 | $1.35M derived: sum of 4 quarters · filed 2023-03-02 | |
| 2021-06-30 | $428.13K 10-Q · filed 2022-08-04 | $1.35M 10-Q · filed 2022-08-04 | $1.35M derived: sum of 3 quarters · filed 2023-03-02 | $1.35M derived: sum of 4 quarters · filed 2023-03-02 | |
| 2021-03-31 | $918.80K 10-Q · filed 2022-05-05 | $918.80K derived: sum of 2 quarters · filed 2023-03-02 | $918.80K derived: sum of 3 quarters · filed 2023-03-02 | $918.80K derived: sum of 4 quarters · filed 2023-03-02 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $0.00 derived: sum of 2 quarters · filed 2023-03-02 | $0.00 derived: sum of 3 quarters · filed 2023-03-02 | $0.00 10-K · filed 2023-03-02 | |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-04 | $0.00 derived: sum of 2 quarters · filed 2021-11-04 | $0.00 10-Q · filed 2021-11-04 | $316.55K derived: sum of 4 quarters · filed 2022-03-03 | |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-05 | $0.00 10-Q · filed 2021-08-05 | $316.55K derived: sum of 3 quarters · filed 2022-03-03 | $1.30M derived: sum of 4 quarters · filed 2022-03-03 | |
| 2020-03-31 | $0.00 10-Q · filed 2021-05-06 | $316.55K derived: sum of 2 quarters · filed 2022-03-03 | $1.30M derived: sum of 3 quarters · filed 2022-03-03 | $1.95M derived: sum of 4 quarters · filed 2022-03-03 | |
| 2019-12-31 | $316.55K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $1.30M derived: sum of 2 quarters · filed 2022-03-03 | $1.95M derived: sum of 3 quarters · filed 2022-03-03 | $5.09M 10-K · filed 2022-03-03 | |
| 2019-09-30 | $981.92K 10-Q · filed 2020-11-05 | $1.64M derived: sum of 2 quarters · filed 2020-11-05 | $4.77M 10-Q · filed 2020-11-05 | ||
| 2019-06-30 | $656.52K 10-Q · filed 2020-08-06 | $3.79M 10-Q · filed 2020-08-06 | |||
| 2019-03-31 | -$3.14M 10-Q · filed 2020-05-06 | ||||
| 2018-12-31 | -$6.92M 10-K · filed 2021-03-04 | ||||
| 2015-09-30 | $0.00 10-Q · filed 2015-10-27 | $0.00 10-Q · filed 2015-10-27 | |||
| 2015-07-26 | -$184.03K 10-Q · filed 2015-10-27 | ||||
| 2014-09-30 | -$11.53K 10-Q · filed 2015-10-27 | -$140.93K derived: sum of 2 quarters · filed 2015-10-27 | -$313.43K 10-Q · filed 2015-10-27 | ||
| 2014-06-19 | -$129.40K 10-Q · filed 2015-10-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |